Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

SHA:600671 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	12.32	17.62	15.25	-38.28	-67.52	-29.8
Depreciation & Amortization	25	24.63	18.58	15.01	18.34	12.3
Other Amortization	9.92	12.55	3.47	1.21	2.42	2.29
Loss (Gain) From Sale of Assets	0.01	0.01	0	-0.33	0.09	-0.04
Asset Writedown & Restructuring Costs	0.1	0.69	0.83	6.01	17.76	2.92
Loss (Gain) From Sale of Investments	1.72	1.71	-0.03	0.53	-0.96	-
Provision & Write-off of Bad Debts	2.24	1.96	2.29	-2.99	4.99	4.05
Other Operating Activities	3.07	-2.36	13.25	11.5	14.05	9.81
Change in Accounts Receivable	-9.73	-50.12	-64.08	-6.41	43.19	-27.41
Change in Inventory	6.75	13.14	-9.38	4.87	-1.15	11.79
Change in Accounts Payable	-3.87	-7.14	-16.42	-11.57	-49.65	-13.93
Change in Other Net Operating Assets	-	-	-	-	-2.13	2.32
Operating Cash Flow	46.95	11.79	-36.67	-20.43	-19.37	-26.42
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-19.15	-31.18	-20.55	-8.96	-3.52	-4.71
Sale of Property, Plant & Equipment	0.02	0.02	0	0.17	0	0.34
Cash Acquisitions	-	-	-6.31	-	-2.2	0.22
Divestitures	-	-	-	-0.04	-0.08	-
Investment in Securities	-	0	-	-	-	-
Investing Cash Flow	-19.14	-31.15	-26.86	-8.83	-5.8	-4.16

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	162.14	149.71	102.45	110.45	181.2
Long-Term Debt Issued	-	-	81.47	59.45	55.65	-
Total Debt Issued	207.85	162.14	231.18	161.9	166.1	181.2
Short-Term Debt Repaid	-	-146.75	-205.75	-162.04	-112.55	-145.83
Long-Term Debt Repaid	-	-9.01	-8.33	-4.78	-60.27	-44.09
Lease Payments	-6.77	-9.01	-8.33	-4.78	-4.42	-3.39
Total Debt Repaid	-175.3	-155.76	-214.09	-166.82	-172.82	-189.92
Net Debt Issued (Repaid)	32.55	6.38	17.09	-4.92	-6.72	-8.72
Issuance of Common Stock	1.77	1.77	7.43	90	0.27	-
Common Dividends Paid	-6.59	-6.5	-8.58	-6.67	-4.78	-6.71
Other Financing Activities	-7.43	-3.48	-2.9	6.41	67.29	49.94
Financing Cash Flow	20.29	-1.83	13.04	84.83	56.06	34.52

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	48.11	-21.19	-50.5	55.57	30.89	3.94

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	27.8	-19.39	-57.23	-29.38	-22.89	-31.13
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	13.40%	-9.16%	-26.34%	-24.13%	-21.02%	-21.17%
Free Cash Flow Per Share	0.23	-0.16	-0.47	-0.24	-0.19	-0.25
Levered Free Cash Flow	22.68	-48.41	-25.67	-12.72	37.87	42.11
Unlevered Free Cash Flow	25.15	-43.91	-22.19	-8.23	42.5	46.71
Free Cash Flow After Leases	21.03	-28.39	-65.56	-34.16	-27.31	-34.52

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	17.76	24.36	13.72	6.13	2.99	8.25
Change in Working Capital	-7.44	-45.03	-90.32	-13.1	-8.55	-27.96

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error